GHRS Valuation

GH Research PLC

Add to Watchlist

Advanced Chart

13.530

+0.2(1.500%)1D

Overview
Forecast
Valuation
Earnings

GHRS Relative Valuation

GHRS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GHRS is overvalued; if below, it's undervalued.

Historical Valuation

GH Research PLC (GHRS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -19.77. The fair price of GH Research PLC (GHRS) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：13.52

Fair

-10.14

Trailing

Forward

-6.95

EV/EBITDA

GH Research PLC. (GHRS) has a current EV/EBITDA of -6.95. The 5-year average EV/EBITDA is -8.76. The thresholds are as follows: Strongly Undervalued below -20.21, Undervalued between -20.21 and -14.49, Fairly Valued between -3.03 and -14.49, Overvalued between -3.03 and 2.70, and Strongly Overvalued above 2.70. The current Forward EV/EBITDA of -6.95 falls within the Historic Trend Line -Fairly Valued range.

-6.85

EV/EBIT

GH Research PLC. (GHRS) has a current EV/EBIT of -6.85. The 5-year average EV/EBIT is -11.83. The thresholds are as follows: Strongly Undervalued below -39.41, Undervalued between -39.41 and -25.62, Fairly Valued between 1.96 and -25.62, Overvalued between 1.96 and 15.74, and Strongly Overvalued above 15.74. The current Forward EV/EBIT of -6.85 falls within the Historic Trend Line -Fairly Valued range.

0.00

GH Research PLC. (GHRS) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

-13.39

P/OCF

GH Research PLC. (GHRS) has a current P/OCF of -13.39. The 5-year average P/OCF is -16.33. The thresholds are as follows: Strongly Undervalued below -32.72, Undervalued between -32.72 and -24.52, Fairly Valued between -8.14 and -24.52, Overvalued between -8.14 and 0.06, and Strongly Overvalued above 0.06. The current Forward P/OCF of -13.39 falls within the Historic Trend Line -Fairly Valued range.

-11.38

P/FCF

GH Research PLC. (GHRS) has a current P/FCF of -11.38. The 5-year average P/FCF is -16.00. The thresholds are as follows: Strongly Undervalued below -33.54, Undervalued between -33.54 and -24.77, Fairly Valued between -7.23 and -24.77, Overvalued between -7.23 and 1.55, and Strongly Overvalued above 1.55. The current Forward P/FCF of -11.38 falls within the Historic Trend Line -Fairly Valued range.

GH Research PLC (GHRS) has a current Price-to-Book (P/B) ratio of 2.73. Compared to its 3-year average P/B ratio of 2.38 , the current P/B ratio is approximately 14.43% higher. Relative to its 5-year average P/B ratio of 2.99, the current P/B ratio is about -8.89% higher. GH Research PLC (GHRS) has a Forward Free Cash Flow (FCF) yield of approximately -4.88%. Compared to its 3-year average FCF yield of -6.42%, the current FCF yield is approximately -23.91% lower. Relative to its 5-year average FCF yield of -5.09% , the current FCF yield is about -4.00% lower.

2.73

P/B

Median3y

2.38

Median5y

2.99

-4.88

FCF Yield

Median3y

-6.42

Median5y

-5.09

Competitors Valuation Multiple

The average P/S ratio for GHRS's competitors is 2248.47, providing a benchmark for relative valuation. GH Research PLC Corp (GHRS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Arbutus Biopharma Corp

Phathom Pharmaceuticals Inc

Praxis Precision Medicines Inc

Spyre Therapeutics Inc

8987.66

923.53M

Performance Decomposition

Market capitalization of GHRS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of GHRS in the past 1 year is driven by Unknown.